CKD cohort Non-CKD cohort Test Entire cohort, n=24 778

Slides:

Advertisements

Similar presentations

Steven M. Wright, PhD Director of Epidemiology Office of Quality and Performance An Analysis of the Quality of Care Provided to Men and Women in the VA.

Advertisements

Claims-Based Quality Measures CMS Physician Group Practice Demonstration Project Chealsea Nather 26 January 2005.

Comprehensive Diabetes Care. Comprehensive Diabetes Care: HbA1c Testing (Commercial) Source: National Committee for Quality Assurance, The State of Health.

Racial Comparisons of Diabetes Care and Intermediate Outcomes in a Patient-Centered Medical Home Featured Article: Joseph A. Simonetti, Michael J. Fine,

The Need for Increased Access to the U.S. Health-Care System by Jesse E. Bible, Richard S. Lee, and Gary E. Friedlaender J Bone Joint Surg Am Volume 91(2):

USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.

The Medical Research Council

A.M. Thompson, T.G. Pickering Kidney International

Percent of patients receiving influenza vaccinations figure 5

American Public Health Association

Chronic Kidney Disease is Common and Expensive and Interacts with Diabetes and Cardiovascular Disease in the Dually-Enrolled Population Funded in part.

Influenza Vaccine Effectiveness Against Pediatric Deaths:

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

Outcomes with trisodium citrate 30% vs heparin as catheter-locking solution (all catheters) in patients on hemodialysis Variable TSC, n (%) Heparin, n.

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Nat. Rev. Nephrol. doi: /nrneph

Health and Disease Management

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Rank-order bar chart of percentage of patient-days with blood glucose results > 299 mg/dl for non-ICU units. Rank-order bar chart of percentage of patient-days.

Figure 5 Risk factor control in the intensive treatment group

Figure 1 The burden of chronic kidney disease (CKD)

Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients Sprague et al.

The Research Question Does self monitoring of blood glucose (SMBG) in patients with non-insulin treated type 2 diabetes improve glycemia or quality of.

Health ABC: Mortality risk by quintile of cystatin C

Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study Flythe et al. Am J Nephrol 2017;45:

Chapter 9: Hypothesis Testing

Distribution of the percentage differences of each basal rate estimate to final basal insulin rates. Distribution of the percentage differences of each.

Chapter 2: Use of iron to treat anemia in CKD

Predictors of disease progression in patients with CKD

Volume 63, Issue 2, Pages (February 2003)

Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.

Langsford et al. Am J Nephrol 2017;45: (DOI: / )

Payan Schober et al. Am J Nephrol 2017;45: (DOI: / )

Health system organisation and informatics pathways for case reporting, patient monitoring and vital statistics systems. ePMS, electronic patient monitoring.

Prevalence of microvascular and macrovascular complications compared between cohort 1 and cohort 2 for subjects with type 2 (A, upper panel) and type 1.

Subgroup analysis of physical activity rates—Asian immigrants versus whites stratified by DM status. Subgroup analysis of physical activity rates—Asian.

Trend of overall improvement in CKD risk categories after bariatric surgery using year 1 post-surgery as baseline. Trend of overall improvement in CKD.

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Yearly trends in percentage of admissions for primary TB cases that occurred in selected high-risk groups from 1992 to 2011: secondary diagnoses of HIV.

IIV induces CD21hiCD27+ and CD21loCD27+ influenza-specific B cells

Targeting Immunity in End-Stage Renal Disease

Kaplan-Meier curves showing the time in months to the first inappropriate shock from the start of remote monitoring in primary and secondary prevention.

The results of the influenza vaccination measured by hemagglutination inhibition assay (HIA) among healthy elderly and elderly patients with type 2 diabetes.

Relationships between annual antibiotic purchase rates and progression of microalbuminuria in patients with type 1 diabetes. Relationships between annual.

Age, cytomegalovirus (CMV) seropositivity in the healthy and type 2 diabetes mellitus (T2DM) and the response to influenza vaccination after the CMV serostatus.

Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

Distribution of responses to the knowledge questions.

Percentage of Florida adults with diagnosed diabetes who received services or engaged in self-management practices by DSME duration category, Florida BRFSS.

HRs for prostate cancer by medication status.

Occupational Life Expectancy in England & Wales,

PEDF inhibits Wnt/T-cell factor/β-catenin signaling in resting and wounded skin. PEDF inhibits Wnt/T-cell factor/β-catenin signaling in resting and wounded.

Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.

Crude and adjusted HbA1c change by medication adherence group (proportion of days covered (PDC)) by linear regression, controlling for age, age2, gender,

Metabolic parameters in the three groups of patients during l-arginine infusion. Metabolic parameters in the three groups of patients during l-arginine.

Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.

Changes in glycated hemoglobin (HbA1c) levels after 12 weeks’ treatment with lixisenatide (according to dose increase regimen) or placebo. Changes in glycated.

Difference in average school grades between offspring born to women with type 1 diabetes and the matched control children, by maternal third trimester.

Mean changes (standard error) from baseline in A1C (A and B) and body weight (C and D) for patients with type 1 (A and C) or type 2 (B and D) diabetes.

Cumulative incidence of pterygium among smokers and never-smokers between 1 January 2004 and 31 December Cumulative incidence of pterygium among.

Plots of average estimated and measured GFR vs

A: Probability of retinopathy-free survival.

Sodium consumption (mg/day) at baseline by demographic characteristics in a cohort of self-referred patients with type 2 diabetes. Sodium consumption (mg/day)

Elevated blood glucose vs time.

Global retinal oxygen saturation in eyes with progression or non-progression of proliferative diabetic retinopathy (PDR) before and after panretinal laser.

Percentage of pneumococcal isolates within each vaccine group for 2001 and Percentage of pneumococcal isolates within each vaccine group for 2001.

Trends in the epidemiology of smoking recorded in UK general practice

Presentation transcript:

Percentage of patients with claims for selected general health tests, by CKD and diabetic status CKD cohort Non-CKD cohort Test Entire cohort, n=24 778 Diabetic, n=12 631 Non-diabetic, n=12 147 Entire cohort, n=24 778 Eye exam 60 — HbA1c 75 74 Echocardiogram* 51 61 41 20 29 18 Stress test* 24 19 15 14 Lipid monitoring 58 68 47 57 72 54 Influenza vaccine* 46 49 42 52 48 Pneumococcal vaccine* 9 10 8 16 Bone densitometry* 5 4 11 12 *Statistically significant difference between the proportion of patients in CKD and non-CKD cohorts who received this test. Kausz AT et al. J Am Soc Nephrol 2005; avalale at: http://www.jasn.org.